Microsurgical Resection of Intramedullary Spinal Cord Metastases

Launched by CANTONAL HOSPITAL OF ST. GALLEN · Sep 15, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effects of surgery on patients with intramedullary spinal cord metastases (ISCM), which are cancerous tumors that grow within the spinal cord. The researchers want to find out if surgical treatment can improve patients' ability to move and function without causing serious complications or increasing the risk of death compared to those who receive non-surgical treatments like radiation therapy. They will look at how well patients do three months, six months, and a year after treatment, focusing on their ability to walk, their overall health, and any complications that may arise.

To be eligible for this study, participants need to be adults who have been treated for ISCM at one of the participating medical centers. Those under 18 are not eligible. During the trial, patients can expect to undergo surgery if they qualify, and their progress will be monitored closely over time. The study aims to provide valuable information that could help improve treatment options for people with this condition in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients admitted to one of the participating centres and treated for ISCM
• • Available documentation of admission and postoperative status
• Exclusion Criteria:
• • - Patients under the age of 18